Vesa Aaltonen

4.5k total citations
27 papers, 715 citations indexed

About

Vesa Aaltonen is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vesa Aaltonen has authored 27 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Ophthalmology, 8 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vesa Aaltonen's work include Retinal Diseases and Treatments (7 papers), Retinal and Optic Conditions (5 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). Vesa Aaltonen is often cited by papers focused on Retinal Diseases and Treatments (7 papers), Retinal and Optic Conditions (5 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). Vesa Aaltonen collaborates with scholars based in Finland, Hungary and Poland. Vesa Aaltonen's co-authors include Juha Peltonen, Jussi Koivunen, Matti Laato, Peter J. Boström, Karl‐Ove Söderström, Petri Lehenkari, Kai Kaarniranta, Outi Hirvonen, Olli Arjamaa and Veli‐Matti Kähäri and has published in prestigious journals such as Cancer Research, American Journal Of Pathology and International Journal of Cancer.

In The Last Decade

Vesa Aaltonen

26 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vesa Aaltonen Finland 14 364 126 115 95 74 27 715
Claudia A. Benavente United States 15 376 1.0× 209 1.7× 97 0.8× 103 1.1× 33 0.4× 24 709
Peter Hovland United States 11 404 1.1× 191 1.5× 82 0.7× 262 2.8× 46 0.6× 16 773
Masahiro Maeda Japan 13 347 1.0× 99 0.8× 35 0.3× 141 1.5× 137 1.9× 42 995
Vanessa Morales-Tirado United States 11 223 0.6× 112 0.9× 90 0.8× 105 1.1× 15 0.2× 26 540
Jeongmin Lee South Korea 18 304 0.8× 145 1.2× 113 1.0× 86 0.9× 14 0.2× 29 812
Ryõ Andõ Japan 13 211 0.6× 58 0.5× 45 0.4× 176 1.9× 30 0.4× 73 591
Shuai Yang China 17 499 1.4× 58 0.5× 231 2.0× 226 2.4× 26 0.4× 35 884
Federico Corti United States 16 403 1.1× 78 0.6× 106 0.9× 21 0.2× 33 0.4× 24 808

Countries citing papers authored by Vesa Aaltonen

Since Specialization
Citations

This map shows the geographic impact of Vesa Aaltonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vesa Aaltonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vesa Aaltonen more than expected).

Fields of papers citing papers by Vesa Aaltonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vesa Aaltonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vesa Aaltonen. The network helps show where Vesa Aaltonen may publish in the future.

Co-authorship network of co-authors of Vesa Aaltonen

This figure shows the co-authorship network connecting the top 25 collaborators of Vesa Aaltonen. A scholar is included among the top collaborators of Vesa Aaltonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vesa Aaltonen. Vesa Aaltonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heloterä, Hanna, et al.. (2024). Analysis of prognostic and predictive factors in neovascular age‐related macular degeneration Kuopio cohort. Acta Ophthalmologica. 102(6). 703–713. 5 indexed citations
2.
Tuulonen, Anja, Marko Kataja, Vesa Aaltonen, et al.. (2021). A comprehensive model for measuring real‐life cost‐effectiveness in eyecare: automation in care and evaluation of system (aces‐rwm™). Acta Ophthalmologica. 100(3). e833–e840. 9 indexed citations
3.
Tuulonen, Anja, Marko Kataja, Vesa Aaltonen, et al.. (2021). A comprehensive model for measuring real-life cost-effectiveness in eyecare: automation in care and evaluation of system (aces-rwm (TM)). STM:n Hallinnonalan avoin julkaisuarkisto (Julkari).
4.
Achiron, Asaf, et al.. (2021). Relationship Between Prolonged Intraocular Inflammation and Macular Edema After Cataract Surgery. Translational Vision Science & Technology. 10(7). 15–15. 6 indexed citations
5.
Tuuminen, Raimo, et al.. (2021). Long-term effects of intravitreal bevacizumab and aflibercept on intraocular pressure in wet age-related macular degeneration. BMC Ophthalmology. 21(1). 312–312. 4 indexed citations
6.
Tuuminen, Raimo, Hannele Uusitalo‐Järvinen, Vesa Aaltonen, et al.. (2017). The Finnish national guideline for diagnosis, treatment and follow‐up of patients with wet age‐related macular degeneration. Acta Ophthalmologica. 95(A105). 1–9. 30 indexed citations
7.
Aaltonen, Vesa, et al.. (2017). Case report: bilateral Mooren ulcer in association with hepatitis C. BMC Ophthalmology. 17(1). 239–239. 4 indexed citations
8.
Arjamaa, Olli, Vesa Aaltonen, Niina Piippo, et al.. (2017). Hypoxia and inflammation in the release of VEGF and interleukins from human retinal pigment epithelial cells. Graefe s Archive for Clinical and Experimental Ophthalmology. 255(9). 1757–1762. 57 indexed citations
9.
Aaltonen, Vesa & Juha Peltonen. (2010). PKCalpha/beta I inhibitor Go6976 induces dephosphorylation of constitutively hyperphosphorylated Rb and G1 arrest in T24 cells.. PubMed. 30(10). 3995–9. 8 indexed citations
10.
Aaltonen, Vesa, Jussi Koivunen, Matti Laato, & Juha Peltonen. (2007). PKC inhibitor Go6976 induces mitosis and enhances doxorubicin-paclitaxel cytotoxicity in urinary bladder carcinoma cells. Cancer Letters. 253(1). 97–107. 13 indexed citations
11.
Leinonen, Pekka, et al.. (2007). Impaired Gap Junction Formation and Intercellular Calcium Signaling in Urinary Bladder Cancer Cells can be Improved by Gö6976. Cell Communication & Adhesion. 14(4). 125–136. 13 indexed citations
12.
Koivunen, Jussi, Seija-Liisa Karvonen, Heli Ylä‐Outinen, et al.. (2005). NF1 tumor suppressor in epidermal wound healing with special focus on wound healing in patients with type 1 neurofibromatosis. Archives of Dermatological Research. 296(12). 547–554. 13 indexed citations
13.
Koivunen, Jussi, Vesa Aaltonen, & Juha Peltonen. (2005). Protein kinase C (PKC) family in cancer progression. Cancer Letters. 235(1). 1–10. 209 indexed citations
14.
Koivunen, Jussi, et al.. (2004). Protein Kinase C α/β Inhibitor Go6976 Promotes Formation of Cell Junctions and Inhibits Invasion of Urinary Bladder Carcinoma Cells. Cancer Research. 64(16). 5693–5701. 83 indexed citations
15.
16.
Boström, Peter J., Laura Ravanti, Niina Reunanen, et al.. (2000). Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder. International Journal of Cancer. 88(3). 417–423. 59 indexed citations
17.
Kalimo, Hannu, et al.. (2000). Wound Healing in Denervated Rat Groin Skin Flap. European Surgical Research. 32(3). 197–202. 11 indexed citations
18.
Aaltonen, Vesa, Peter J. Boström, Karl‐Ove Söderström, et al.. (1999). Urinary Bladder Transitional Cell Carcinogenesis Is Associated with Down-Regulation of NF1 Tumor Suppressor Gene in Vivo and in Vitro. American Journal Of Pathology. 154(3). 755–765. 39 indexed citations
19.
20.
Hirvonen, Outi, Jouni Lakkakorpi, Vesa Aaltonen, et al.. (1998). Developmental regulation of NF1 tumor suppressor gene in human peripheral nerve. Journal of Neurocytology. 27(12). 939–951. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia A. Benavente Breakdown of academic impact, for papers by Peter Hovland Breakdown of academic impact, for papers by Masahiro Maeda Breakdown of academic impact, for papers by Vanessa Morales-Tirado Breakdown of academic impact, for papers by Jeongmin Lee Breakdown of academic impact, for papers by Ryõ Andõ Breakdown of academic impact, for papers by Shuai Yang Breakdown of academic impact, for papers by Federico Corti
Rankless by CCL
2026